Literature DB >> 32763192

Excess mortality from COVID-19 in an English sentinel network population.

Mark Joy1, F D Richard Hobbs1, Dylan McGagh1, Oluwafunmi Akinyemi1, Simon de Lusignan2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32763192      PMCID: PMC7402647          DOI: 10.1016/S1473-3099(20)30632-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
There have been several attempts to predict mortality from COVID-19 in the UK, including calculation of age-based case fatality rates and relative risk (RR) of mortality. David Spiegelhalter said that “roughly speaking, we might say that getting COVID-19 is like packing a year's worth of risk into a week or two”. In response to these predictions, we decided to calculate the excess mortality in the Oxford Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) cohort. The RCGP RSC cohort has been recruited to be nationally representative, and the mortality data for the cohort align well with those from the Office of National Statistics (ONS; appendix p 1). Our excess mortality estimate was based on an additive hazard model separating the observed mortality hazard into a sum of background—or expected—mortality and an excess term, assuming that the number of deaths (both observed and expected) followed a Poisson distribution. We used robust standard errors to address overdispersion and potential violation of the Poisson assumption. The expected or background mortality was estimated from life tables reported in ONS figures, downloaded from the Human Mortality Database. These life tables give the annual probability of death according to sex, calendar year, and age, and we can extrapolate to obtain mortality risk in the period considered. In the additive hazard model, excess mortality was obtained by subtracting the expected mortality from the observed mortality. In this way, excess mortality can be interpreted as the mortality directly or indirectly related to the disease of interest (after excluding all other causes of death). Between weeks 2 and 20 of 2020, we observed 1 573 648 person-years of follow-up (4·41 million individuals observed for 0·36 years) and 17 130 deaths (appendix p 2). Based on background mortality for the same period in 2019, we would have expected 6069 deaths for this period had the COVID-19 pandemic and lockdown not happened. The resulting absolute excess risk (the difference between observed and expected deaths, divided by person-years at risk) was 702·9 per 100 000 person-years (95% CI 686·8–719·3). For comparison, the ONS estimate for mortality in the UK population for the entirety of 2018 was 902 per 100 000 person-years. As measured by the RCGP RSC data, excess mortality rose steadily from week 13 to a peak between weeks 15 and 16, after which a steady decline was observed. Around weeks 20–22, cohort mortality merged with the background or expected mortality (data not shown). We conclude that in about a third of the year, the excess risk amounted to three-quarters of the deaths we might have anticipated in the whole of the previous year. Sharing this estimate might be of help in modelling for future waves of infection and quantifying the impact of future mitigation strategies.
  10 in total

1.  Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.

Authors:  Heather Whitaker; Ruby S M Tsang; Elizabeth Button; Nick Andrews; Rachel Byford; Ray Borrow; F D Richard Hobbs; Tim Brooks; Gary Howsam; Kevin Brown; Jack Macartney; Charlotte Gower; Cecilia Okusi; Jacqueline Hewson; Julian Sherlock; Ezra Linley; Manasa Tripathy; Ashley D Otter; John Williams; Simon Tonge; Simon de Lusignan; Gayatri Amirthalingam
Journal:  J Infect       Date:  2022-04-09       Impact factor: 38.637

Review 2.  The Spill-Over Impact of the Novel Coronavirus-19 Pandemic on Medical Care and Disease Outcomes in Non-communicable Diseases: A Narrative Review.

Authors:  Ivy Lynn Mak; Eric Yuk Fai Wan; Teenie Kwan Tung Wong; Wendy Woo Jung Lee; Esther Wai Yin Chan; Edmond Pui Hang Choi; Celine Sze Ling Chui; Mary Sau Man Ip; Wallace Chak Sing Lau; Kui Kai Lau; Shing Fung Lee; Ian Chi Kei Wong; Esther Yee Tak Yu; Cindy Lo Kuen Lam
Journal:  Public Health Rev       Date:  2022-04-27

3.  AIDS and COVID: A tale of two pandemics and the role of statisticians.

Authors:  Susan S Ellenberg; Jeffrey S Morris
Journal:  Stat Med       Date:  2021-05-20       Impact factor: 2.373

4.  Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England.

Authors:  Mark Joy; Fd Richard Hobbs; Jamie Lopez Bernal; Julian Sherlock; Gayatri Amirthalingam; Dylan McGagh; Oluwafunmi Akinyemi; Rachel Byford; Gavin Dabrera; Jienchi Dorward; Joanna Ellis; Filipa Ferreira; Nicholas Jones; Jason Oke; Cecilia Okusi; Brian D Nicholson; Mary Ramsay; James P Sheppard; Mary Sinnathamby; Maria Zambon; Gary Howsam; John Williams; Simon de Lusignan
Journal:  Br J Gen Pract       Date:  2020-11-26       Impact factor: 5.386

5.  Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study.

Authors:  Christopher R Wilcox; Nazrul Islam; Hajira Dambha-Miller
Journal:  BMJ Open Respir Res       Date:  2021-03

6.  The dynamics of frailty development and progression in older adults in primary care in England (2006-2017): a retrospective cohort profile.

Authors:  Carole Fogg; Simon D S Fraser; Paul Roderick; Simon de Lusignan; Andrew Clegg; Sally Brailsford; Abigail Barkham; Harnish P Patel; Vivienne Windle; Scott Harris; Shihua Zhu; Tracey England; Dave Evenden; Francesca Lambert; Bronagh Walsh
Journal:  BMC Geriatr       Date:  2022-01-06       Impact factor: 3.921

7.  Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data.

Authors:  Eleftheria Vasileiou; Ting Shi; Steven Kerr; Chris Robertson; Mark Joy; Ruby Tsang; Dylan McGagh; John Williams; Richard Hobbs; Simon de Lusignan; Declan Bradley; Dermot OReilly; Siobhan Murphy; Antony Chuter; Jillian Beggs; David Ford; Chris Orton; Ashley Akbari; Stuart Bedston; Gareth Davies; Lucy J Griffiths; Rowena Griffiths; Emily Lowthian; Jane Lyons; Ronan A Lyons; Laura North; Malorie Perry; Fatemeh Torabi; James Pickett; Jim McMenamin; Colin McCowan; Utkarsh Agrawal; Rachael Wood; Sarah Jane Stock; Emily Moore; Paul Henery; Colin R Simpson; Aziz Sheikh
Journal:  BMJ Open       Date:  2022-02-14       Impact factor: 3.006

8.  A Comparative Analysis of In-Hospital Mortality per Disease Groups in Germany Before and During the COVID-19 Pandemic From 2016 to 2020.

Authors:  Sebastian König; Vincent Pellissier; Sven Hohenstein; Johannes Leiner; Gerhard Hindricks; Andreas Meier-Hellmann; Ralf Kuhlen; Andreas Bollmann
Journal:  JAMA Netw Open       Date:  2022-02-01

9.  Developing a Long COVID Phenotype for Postacute COVID-19 in a National Primary Care Sentinel Cohort: Observational Retrospective Database Analysis.

Authors:  Nikhil Mayor; Bernardo Meza-Torres; Cecilia Okusi; Gayathri Delanerolle; Martin Chapman; Wenjuan Wang; Sneha Anand; Michael Feher; Jack Macartney; Rachel Byford; Mark Joy; Piers Gatenby; Vasa Curcin; Trisha Greenhalgh; Brendan Delaney; Simon de Lusignan
Journal:  JMIR Public Health Surveill       Date:  2022-08-11

10.  Analysis of COVID-19 outbreak origin in China in 2019 using differentiation method for unusual epidemiological events.

Authors:  Vladan Radosavljevic
Journal:  Open Med (Wars)       Date:  2021-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.